Today at @ClevelandClinic, we celebrated a major milestone: completion of enrollment for our randomized clinical trial comparing #BariatricSurgery, #Semaglutide, and #Tirzepatide.
Proud and grateful to work with an incredible team advancing the future of #obesity care & science.
Excited to start the inaugural Marrow Master Class @karmanoscancer with fellow myeloid experts like @Dr_AmerZeidan@CloneTracker & many others ! Great meeting in beautiful Detroit Michigan organized by Dr. Suresh Balasubramaniam.
Congratulations to @RabiHannaMD my friend and colleague at @ClevelandClinic for leading the practice changing study on CRISPR gene editing for Sickle Cell Disease chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://t.co/dKLGWNoFov @NEJM@OncoAlert@IMG_Oncologists
Shay Taylor-Allen learned last week that she had matched with her first-choice residency pick, Yale School of Medicine — the very same hospital where she was born and later worked as a janitor. ABC News' Danny New has the story. https://t.co/Y4mQi3aXMr
Proud to be part of this study, finally linking Agent Orange exposure to ‘aggressive’ bone marrow cancers in Vietnam vets. Let's get these Veterans the service connection they deserve. @SylvesterCancer@UMiamiHealth@NIH@theNCI@nancykgillis@AmyDeZern https://t.co/un09GuR80R
So proud of you, Anmol! 🙌 Your dedication + hard work made this longitudinal dataset possible. Big momentum for our growing CHIP Clinical & Research Program as we scale; stay tuned, more to come! 👏🧬 @clevelclinicmd #ClevelandClinic#CHIP#CancerSurvivorship#NGS#AACR26
Shoutout to our CHIP team and especially my mentor @CloneTracker for his guidance on our work looking at longitudinal clonal evolution/stability in cancer survivors! Grateful to @AACR for the award and opportunity to share our findings.
@CCF_IMCHIEFS
As the year comes to a close grateful for the dedication, compassion, and teamwork of our incredible colleagues. It is a privilege to work with An amazing group of Hemonc leaders who make a difference for our patients @ClevelandClinic @CleClinicMD
🌟My ASH 2025 experience was filled with mentorship, inspiration, and community. @ASH_hematology
🩸 Career advice with the #BloodBuddies — @GabyHobbs@hamiltkyb@CloneTracker and connecting with friends at #ASHPalooza
💡 Powerful stories and guidance at the Women in Hematology Welcome Reception with @b_avalos_MD together with @mehndz@IzelOkcuMD
🎶 So much fun at the Miami Night Sylvester's reception
🐶 Puppy therapy = pure joy
🤝 Connecting with Mayo Clinic Florida fellows @yajur_arya@Arshi_Syal@Meddoc77 and making new Florida friends
🤩 Meeting wonderful people at the poster sessions 💖
#ASH25 #HemeTwitter #WomenInHeme #MedTwitter #Mentorship #Hematology
Our second paper on this theme introduces the TMNRS, a straightforward, office‑based risk-score to stratify common solid cancer survivors by risk of therapy‑related myeloid neoplasms.
https://t.co/RnxZUMXobT
Link to TMNRS calculator: https://t.co/r1Wp22SzZJ
📊 Our SEER-Medicare study highlights risk factors for secondary myeloid neoplasms after hematologic cancers. Beyond chemotherapy, age, G-CSF exposure & autoimmunity play key roles. Important insights for survivorship care.
@CloneTracker@BMTjunkie@MeganHerrPhD@SwapnaThota